from United European Gastroenterology
Long-term use of aspirin may reduce risk
of digestive cancers. A European study of
more than six hundred thousand people
showed a forty-seven percent lower risk of
liver and esophageal cancers, thirty-eight
percent reduction in incidence of gastric
cancer, thirty-four percent lower incidence
of pancreatic cancer and twenty-four
percent lower incidence of colon cancer.
Even reductions in leukemia, lung and
prostate cancers were observed by
researchers. This study was presented to
the United European Gastroenterology
event in Barcelona. While aspirin is readily
available without prescription for pain
relief, long-term use may have side effects
for some people and is a topic that should
be discussed with your doctor.